Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-Up of Ureteral Stones ≤4 mm: Evaluate the Proportion of Spontaneous Passage and Assess if Symptoms and Stone Characteristics Can Predict Stone Passage

NCT07176026 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07176026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07176026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-Up of Ureteral Stones ≤4 mm: Evaluate the Proportion of Spontaneous Passage and Assess if Symptoms and Stone Characteristics Can Predict Stone Passage
Lead sponsor
Region Skane
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 1, 2025
Completion date
January 1, 2027
Enrollment
1,600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney stone